Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022

Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022

FromBack Bay Life Science Report


Gene Editing to Cross-Species Transplantation: The Most Compelling Healthcare Stories of 2022

FromBack Bay Life Science Report

ratings:
Length:
37 minutes
Released:
Jan 24, 2023
Format:
Podcast episode

Description

In our first podcast episode of 2023, Back Bay’s strategic advisors summarize some of the most compelling healthcare development stories from 2022. From CRISPR and gene editing advancement to cross-species organ transplantation and the latest in the evolving regulatory and reimbursement landscape,  these stories captivated us and continue to herald progress in health and human care. Podcast experts include Brendan Wang, Christian Thienel and Peter Bak, with special thanks to Micheka Fenelon.
Released:
Jan 24, 2023
Format:
Podcast episode

Titles in the series (27)

Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, strategic, and financial analysis at the intersection of science and business.